Sheehy, Susanne H <br/><br/>
ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans.  [electronic resource] 

 -  Molecular therapy : the journal of the American Society of Gene Therapy  Dec 2012 
 - 2355-68 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1525-0024 
<br/><br/><label>Standard No.: </label>10.1038/mt.2012.223  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviruses, Simian--genetics<br/>Animals<br/>Antigens, Protozoan--immunology<br/>Culicidae--parasitology<br/>Flow Cytometry<br/>Humans<br/>Malaria Vaccines--administration & dosage<br/>Malaria, Falciparum--immunology<br/>Merozoite Surface Protein 1--immunology<br/>Orthopoxvirus--immunology<br/>Pan troglodytes--virology